Synthesis and biological assessment of indole derivatives containing penta-heterocycles scaffold as novel anticancer agents towards A549 and K562 cells
作者:Guanglong Zhang、Zhenhua Tang、Sili Fan、Chengpeng Li、Yan Li、Weiqin Liu、Xuesha Long、Wenjing Zhang、Yi Zhang、Zhurui Li、Zhenchao Wang、Danping Chen、Guiping Ouyang
DOI:10.1080/14756366.2022.2163393
日期:2023.12.31
2-chloro-N-(5-(2-oxoindolin-3-yl)-4H-pyrazol-3-yl) acetamide derivatives containing 1,3,4-thiadiazole (10a–i) and 4H-1,2,4-triazol-4-amine (11a–r) moiety was designed, synthesised as novel anticancer agents. The antiproliferative activity values indicated that compound 10 b stood as the most potent derivative with IC50 values of 12.0 nM and 10 nM against A549 and K562 cells, respectively. Mechanism investigation and
摘要 在此,一系列新的 2- chloro- N- (5-(2-oxoindolin-3-yl)-4 H -pyrazol-3-yl) 乙酰胺衍生物包含 1,3,4 - thiadiazole ( 10a – i ) 和4 H -1,2,4-triazol-4-amine ( 11a – r ) 部分被设计、合成为新型抗癌药物。抗增殖活性值表明化合物10b是最有效的衍生物,对 A549 和 K562 细胞的 IC 50值分别为 12.0 nM 和 10 nM。10 b的机理调查和对接研究表明它具有良好的凋亡特性和剂量依赖性的 A549 和 K562 细胞生长停滞,阻断细胞周期进入 G2/M 期。有趣的是,10 b通过调节 EGFR 和 p53-MDM2 介导的途径抑制了 A549 和 K562 细胞的生长。